Wilson Sonsini Goodrich & Rosati advised Automation Anywhere on the deal. Automation Anywhere, a global leader in robotic process automation (RPA), announced that it has entered...
Automation Anywhere’s Acquisition of FortressIQ
IDX’s Business Combination with ZeroFox and L&F Acquisition Corp.
Wilson Sonsini Goodrich & Rosati advised IDX on the deal. Kirkland & Ellis counseled L&F Acquisition Corp. (NYSE: LNFA) on the deal. Venable and Ogier represented...
Advent International’s Acquisition of Majority Stake in Encora
J.P. Morgan acted as exclusive financial advisor to Encora in connection with the transaction and Wilson, Sonsini, Goodrich & Rosati LLP served as legal advisor. Credit...
Addi’s $200 Million Equity and Debt Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Cuatrecasas advised Addi on the deal. Wilson Sonsini Goodrich & Rosati and Philippi Prietocarrizosa Ferrero DU & Uría...
Samsara Inc.’s $805 Million Initial Public Offering
Freshfields advised Morgan Stanley on the deal while Wilson Sonsini Goodrich & Rosati represented Samsara. Morgan Stanley acted as representative of the underwriters on the initial...
Regor Therapeutics’ Collaboration with Lilly
Wilson Sonsini Goodrich & Rosati advised Regor Therapeutics on the deal. Eli Lilly and Company and Regor Therapeutics Group entered into a multi-year research collaboration and...
Innovaccer’s $150 Million Series E Round
Wilson Sonsini Goodrich & Rosati advised Innovaccer on the deal. Innovaccer Inc. announced a $150 million Series E round at a $3.2 billion valuation, driven by...
Chroma Medicine’s $125 Million Financing
Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal. Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in...
HashiCorp’s Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised HashiCorp on the deal. Latham & Watkins represented the underwriters. HashiCorp®, a leader in multi-cloud infrastructure automation software, announced the pricing...
Panther Labs’ $120 Million Series B
Wilson Sonsini Goodrich & Rosati advised Panther Labs on the deal. Panther Labs, a cloud-scale security analytics platform trusted by leading brands, announced $120 million in...
AppLovin’s Shares Offering
Wilson Sonsini Goodrich & Rosati advised AppLovin on the deal. AppLovin Corporation, a leading marketing software company, announced the pricing of its underwritten public offering of...
Recursion’s Collaboration with Roche and Genentech
Wilson Sonsini Goodrich & Rosati advised Recursion on the deal. Recursion, a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development,...